Charcot neuroarthropathy

Disease1 paper1 finding

  • Humans1

Associations

1

GLP-1 receptor agonists

upin humans1HR 1.993Low certainty

1 study

  1. GLP-1 receptor agonists raise the risk of Charcot neuroarthropathy in humans (HR 1.993, 95% CI 1.297-3.064).

    Humansin T2DM patients with neuropathy compared to DPP-4 inhibitors1 yearn = 19,770

    GLP-1 receptor agonists vs DPP-4 inhibitors and neuropathic complications in type 2 diabetes · Journal of neurology · 7 Sep 2026

GLP-1 receptor agonists →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01

Related